| Bacillus anthracis |
Anthrax lethal factor |
FC |
5.6 |
None |
10.1128/aac.01184-06 |
| Bos taurus |
Alpha-chymotrypsin |
IC50 |
2.0 |
None |
10.1021/jm030191r |
| Bos taurus |
Alpha-chymotrypsin |
IC50 |
3.0 |
None |
10.1021/jm030191r |
| Bos taurus |
Alpha-chymotrypsin |
IC50 |
175000.0 |
nM |
10.1021/jm030191r |
| Canis lupus familiaris |
Brain |
Fu |
0.006 |
None |
10.1124/dmd.111.038778 |
| Canis lupus familiaris |
Canis familiaris |
AV block |
100.0 |
None |
10.1021/jm00130a029 |
| Canis lupus familiaris |
Canis familiaris |
CL |
48.0 |
mL.min-1.kg-1 |
10.1021/jm991030j |
| Canis lupus familiaris |
Canis familiaris |
Clearance |
16.0 |
ul min-1 |
10.1021/jm991030j |
| Canis lupus familiaris |
Canis familiaris |
ED30 |
3.0 |
ug kg-1 |
10.1021/jm00130a029 |
| Canis lupus familiaris |
Canis familiaris |
ED30 |
175.0 |
ug kg-1 |
10.1021/jm00130a029 |
| Canis lupus familiaris |
Canis familiaris |
T1/2 |
0.09333 |
hr |
10.1021/jm00130a029 |
| Canis lupus familiaris |
Canis familiaris |
Tp |
1.2 |
min |
10.1021/jm00130a029 |
| Enterobacter cloacae |
Beta-lactamase |
IC50 |
50.0 |
None |
10.1021/jm030191r |
| Escherichia coli |
AmpC |
Activity |
nan |
None |
10.1021/jm801605r |
| Escherichia coli K-12 |
Beta-lactamase AmpC |
IC50 |
50.0 |
None |
10.1021/jm030191r |
| Escherichia coli K-12 |
Beta-lactamase AmpC |
IC50 |
20000.0 |
nM |
10.1021/jm030191r |
| Escherichia coli K-12 |
Beta-lactamase AmpC |
IC50 |
20000.0 |
nM |
10.1021/jm030266r |
| Escherichia coli K-12 |
Beta-lactamase AmpC |
Inhibition |
32.0 |
% |
10.1021/jm030266r |
| Escherichia coli K-12 |
Beta-lactamase AmpC |
Inhibition |
33.0 |
% |
10.1021/jm030266r |
| Escherichia coli K-12 |
Beta-lactamase AmpC |
Inhibition |
81.0 |
% |
10.1021/jm030266r |
| Homo sapiens |
A549 |
Activity |
nan |
None |
10.1021/acs.jmedchem.8b01044 |
| Homo sapiens |
Acetylcholinesterase |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Adenosine A3 receptor |
AC50 |
1695.5 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Adenosine A3 receptor |
Ki |
3250.0 |
nM |
10.1021/jm9600205 |
| Homo sapiens |
Adrenergic receptor alpha-2 |
IC50 |
10000.0 |
nM |
10.1021/jm00126a042 |
| Homo sapiens |
Alpha-1a adrenergic receptor |
AC50 |
746.9 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-1a adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2a adrenergic receptor |
AC50 |
13081.9 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Androgen Receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
ASPC1 |
Activity |
nan |
None |
10.1021/acs.jmedchem.8b01044 |
| Homo sapiens |
Ataxin-2 |
Potency |
19952.6 |
nM |
None |
| Homo sapiens |
Ataxin-2 |
Potency |
35481.3 |
nM |
None |
| Homo sapiens |
ATPase family AAA domain-containing protein 5 |
Potency |
16353.5 |
nM |
None |
| Homo sapiens |
ATPase family AAA domain-containing protein 5 |
Potency |
23099.9 |
nM |
None |
| Homo sapiens |
ATP-binding cassette sub-family G member 2 |
IC50 |
4800.0 |
nM |
10.1016/j.ejmech.2022.114346 |
| Homo sapiens |
ATP-binding cassette sub-family G member 2 |
IC50 |
16595.87 |
nM |
10.1016/j.bmc.2008.07.034 |
| Homo sapiens |
Beta-glucocerebrosidase |
Potency |
7943.3 |
nM |
None |
| Homo sapiens |
Beta-glucocerebrosidase |
Potency |
25118.9 |
nM |
None |
| Homo sapiens |
Bile salt export pump |
IC50 |
7870.0 |
nM |
10.1093/toxsci/kft176 |
| Homo sapiens |
Bile salt export pump |
IC50 |
7900.0 |
nM |
10.1002/hep.27206 |
| Homo sapiens |
Bile salt export pump |
IC50 |
7900.0 |
nM |
10.1021/acs.jmedchem.0c00524 |
| Homo sapiens |
Bile salt export pump |
IC50 |
7900.0 |
nM |
10.1093/toxsci/kfq269 |
| Homo sapiens |
Bile salt export pump |
IC50 |
10000.0 |
nM |
10.1124/dmd.112.047068 |
| Homo sapiens |
Caco-2 |
Activity |
nan |
None |
10.1021/acs.jmedchem.8b01044 |
| Homo sapiens |
Canalicular multispecific organic anion transporter 1 |
Activity |
59.0 |
% |
10.1021/jm7015683 |
| Homo sapiens |
Canalicular multispecific organic anion transporter 1 |
IC50 |
133000.0 |
nM |
10.1093/toxsci/kft176 |
| Homo sapiens |
Canalicular multispecific organic anion transporter 2 |
IC50 |
133000.0 |
nM |
10.1093/toxsci/kft176 |
| Homo sapiens |
Chromobox protein homolog 1 |
Potency |
22387.2 |
nM |
None |
| Homo sapiens |
Cyclooxygenase-1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cytochrome P450 1A2 |
IC50 |
13300.0 |
nM |
10.1124/dmd.112.048264 |
| Homo sapiens |
Cytochrome P450 1A2 |
IC50 |
30000.0 |
nM |
10.1124/dmd.111.043505 |
| Homo sapiens |
Cytochrome P450 2C19 |
IC50 |
560.0 |
nM |
10.1124/dmd.112.048264 |
| Homo sapiens |
Cytochrome P450 2C19 |
IC50 |
3300.0 |
nM |
10.1124/dmd.111.043505 |
| Homo sapiens |
Cytochrome P450 2C8 |
IC50 |
1560.0 |
nM |
10.1124/dmd.111.043505 |
| Homo sapiens |
Cytochrome P450 2C9 |
IC50 |
378.0 |
nM |
10.1124/dmd.111.043505 |
| Homo sapiens |
Cytochrome P450 2C9 |
IC50 |
660.0 |
nM |
10.1124/dmd.112.048264 |
| Homo sapiens |
Cytochrome P450 2C9 |
Ki |
280.0 |
nM |
10.1021/jm030972s |
| Homo sapiens |
Cytochrome P450 2D6 |
IC50 |
1590.0 |
nM |
10.1124/dmd.111.043505 |
| Homo sapiens |
Cytochrome P450 2D6 |
IC50 |
1780.0 |
nM |
10.1124/dmd.112.048264 |
| Homo sapiens |
Cytochrome P450 2J2 |
Activity |
5.8 |
% |
10.1124/dmd.111.043505 |
| Homo sapiens |
Cytochrome P450 2J2 |
Activity |
8.9 |
% |
10.1124/dmd.111.043505 |
| Homo sapiens |
Cytochrome P450 2J2 |
IC50 |
1690.0 |
nM |
10.1124/dmd.112.048264 |
| Homo sapiens |
Cytochrome P450 3A4 |
Activity |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 3A4 |
IC50 |
380.0 |
nM |
10.1124/dmd.112.048264 |
| Homo sapiens |
Cytochrome P450 3A4 |
IC50 |
420.0 |
nM |
10.1021/jm021012t |
| Homo sapiens |
Cytochrome P450 3A4 |
IC50 |
30000.0 |
nM |
10.1124/dmd.111.043505 |
| Homo sapiens |
DNA polymerase kappa |
Potency |
33587.5 |
nM |
None |
| Homo sapiens |
Dopamine D1 receptor |
AC50 |
1883.3 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D1 receptor |
Potency |
1835.5 |
nM |
None |
| Homo sapiens |
Dopamine D1 receptor |
Potency |
7079.5 |
nM |
None |
| Homo sapiens |
Dopamine D3 receptor |
AC50 |
3686.3 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine transporter |
AC50 |
2740.2 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Estrogen receptor alpha |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Flap endonuclease 1 |
Potency |
4228.4 |
nM |
None |
| Homo sapiens |
Gamma-aminobutyric acid receptor subunit alpha-1/alpha-2/beta-2/gamma-2 |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Geminin |
Potency |
31238.4 |
nM |
None |
| Homo sapiens |
H4 |
Activity |
84.62 |
% |
10.1073/pnas.0709695104 |
| Homo sapiens |
H4 |
Activity |
104.77 |
% |
10.1073/pnas.0709695104 |
| Homo sapiens |
H4 |
Activity |
112.51 |
% |
10.1073/pnas.0709695104 |
| Homo sapiens |
H4 |
Activity |
121.03 |
% |
10.1073/pnas.0709695104 |
| Homo sapiens |
H4 |
Activity |
122.6 |
% |
10.1073/pnas.0709695104 |
| Homo sapiens |
H4 |
Activity |
126.59 |
% |
10.1073/pnas.0709695104 |
| Homo sapiens |
H4 |
Activity |
131.58 |
% |
10.1073/pnas.0709695104 |
| Homo sapiens |
H4 |
Activity |
132.05 |
% |
10.1073/pnas.0709695104 |
| Homo sapiens |
H4 |
Activity |
169.02 |
% |
10.1073/pnas.0709695104 |
| Homo sapiens |
H4 |
Activity |
197.46 |
% |
10.1073/pnas.0709695104 |
| Homo sapiens |
H4 |
Activity |
229.64 |
% |
10.1073/pnas.0709695104 |
| Homo sapiens |
H4 |
Activity |
nan |
None |
10.1073/pnas.0709695104 |
| Homo sapiens |
HEK293 |
Potency |
7304.8 |
nM |
None |
| Homo sapiens |
HERG |
AC50 |
3200.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
HET-1A |
Activity |
nan |
None |
10.1021/acs.jmedchem.8b01044 |
| Homo sapiens |
Histamine H3 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histone acetyltransferase GCN5 |
Potency |
28183.8 |
nM |
None |
| Homo sapiens |
Histone deacetylase 6 |
Inhibition |
-39.58 |
% |
10.6019/CHEMBL4808148 |
| Homo sapiens |
Histone deacetylase 6 |
Inhibition |
0.59 |
% |
10.6019/CHEMBL4808148 |
| Homo sapiens |
Histone-lysine N-methyltransferase, H3 lysine-9 specific 3 |
Potency |
29934.9 |
nM |
None |
| Homo sapiens |
Homo sapiens |
Activity |
nan |
None |
10.1002/hep.27206 |
| Homo sapiens |
Homo sapiens |
AUC |
345.26 |
ng.hr.mL-1 |
10.1093/toxsci/kft176 |
| Homo sapiens |
Homo sapiens |
CL |
7.0 |
mL.min-1.kg-1 |
10.1021/jm991030j |
| Homo sapiens |
Homo sapiens |
CL |
10.9 |
mL.min-1.kg-1 |
10.1021/jm901371v |
| Homo sapiens |
Homo sapiens |
CL |
11.0 |
mL.min-1.kg-1 |
10.1021/jm900403j |
| Homo sapiens |
Homo sapiens |
CL |
11.0 |
mL.min-1.kg-1 |
10.1021/jm901371v |
| Homo sapiens |
Homo sapiens |
Clearance |
7.3 |
ul min-1 |
10.1021/jm991030j |
| Homo sapiens |
Homo sapiens |
CL_renal |
0.1 |
mL.min-1.kg-1 |
10.1021/jm901371v |
| Homo sapiens |
Homo sapiens |
CL_renal |
0.11 |
mL.min-1.kg-1 |
10.1021/jm900403j |
| Homo sapiens |
Homo sapiens |
Cmax |
81.0 |
nM |
10.1002/hep.27206 |
| Homo sapiens |
Homo sapiens |
Css |
0.03 |
uM |
10.1093/toxsci/kft176 |
| Homo sapiens |
Homo sapiens |
DILI_Concern |
nan |
None |
10.1016/j.drudis.2016.02.015 |
| Homo sapiens |
Homo sapiens |
DILI_severity_class |
3.0 |
None |
10.1016/j.drudis.2016.02.015 |
| Homo sapiens |
Homo sapiens |
Fa |
0.95 |
None |
10.1021/jm901371v |
| Homo sapiens |
Homo sapiens |
Fabs |
100.0 |
% |
10.1124/dmd.110.034629 |
| Homo sapiens |
Homo sapiens |
F_fraction |
0.11 |
None |
10.1021/jm901371v |
| Homo sapiens |
Homo sapiens |
Fg |
0.21 |
None |
10.1021/jm901371v |
| Homo sapiens |
Homo sapiens |
Fh |
0.53 |
None |
10.1021/jm901371v |
| Homo sapiens |
Homo sapiens |
Vdss |
0.98 |
L.kg-1 |
10.1016/j.ejmech.2009.06.004 |
| Homo sapiens |
Homo sapiens |
Vdss |
1.0 |
L.kg-1 |
10.1021/jm901371v |
| Homo sapiens |
Liver microsomes |
CL |
300.0 |
mL.min-1.g-1 |
10.1016/j.bmcl.2011.12.005 |
| Homo sapiens |
Malate dehydrogenase cytoplasmic |
IC50 |
50000.0 |
nM |
10.1021/jm030191r |
| Homo sapiens |
Microtubule-associated protein tau |
Potency |
8912.5 |
nM |
None |
| Homo sapiens |
Microtubule-associated protein tau |
Potency |
19952.6 |
nM |
None |
| Homo sapiens |
Monoamine oxidase A |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
M-phase phosphoprotein 8 |
Potency |
37685.8 |
nM |
None |
| Homo sapiens |
Multidrug resistance-associated protein 4 |
IC50 |
88000.0 |
nM |
10.1093/toxsci/kft176 |
| Homo sapiens |
Mu opioid receptor |
AC50 |
7461.1 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M1 |
AC50 |
1241.4 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M2 |
AC50 |
424.4 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Niemann-Pick C1 protein |
Potency |
115820.8 |
nM |
None |
| Homo sapiens |
Norepinephrine transporter |
AC50 |
397.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Nuclear factor erythroid 2-related factor 2 |
Potency |
14581.0 |
nM |
None |
| Homo sapiens |
PC-3 |
Activity |
nan |
None |
10.1021/acs.jmedchem.8b01044 |
| Homo sapiens |
Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 |
Potency |
6.0 |
nM |
None |
| Homo sapiens |
P-glycoprotein 1 |
Activity |
18.0 |
nM/mg*min |
10.1021/jm021012t |
| Homo sapiens |
P-glycoprotein 1 |
Activity |
100.0 |
% |
10.1021/jm021012t |
| Homo sapiens |
P-glycoprotein 1 |
Activity |
nan |
None |
10.1023/a:1007692622216 |
| Homo sapiens |
P-glycoprotein 1 |
Activity |
nan |
None |
None |
| Homo sapiens |
P-glycoprotein 1 |
Hill coefficient |
2.44 |
None |
10.1016/j.bmc.2007.07.024 |
| Homo sapiens |
P-glycoprotein 1 |
IC50 |
950.0 |
nM |
10.1021/jm021012t |
| Homo sapiens |
P-glycoprotein 1 |
IC50 |
2300.0 |
nM |
10.1021/jm021012t |
| Homo sapiens |
P-glycoprotein 1 |
IC50 |
3200.0 |
nM |
10.1006/bbrc.2001.6000 |
| Homo sapiens |
P-glycoprotein 1 |
IC50 |
4540.0 |
nM |
10.1016/s0928-0987(02)00082-9 |
| Homo sapiens |
P-glycoprotein 1 |
IC50 |
4786.3 |
nM |
10.1016/j.bmc.2007.07.024 |
| Homo sapiens |
P-glycoprotein 1 |
IC50 |
4786.3 |
nM |
10.1016/j.bmc.2008.07.034 |
| Homo sapiens |
P-glycoprotein 1 |
IC50 |
5128.61 |
nM |
10.1016/j.bmc.2007.07.024 |
| Homo sapiens |
P-glycoprotein 1 |
IC50 |
5600.0 |
nM |
10.1006/bbrc.2001.6000 |
| Homo sapiens |
P-glycoprotein 1 |
IC50 |
6600.0 |
nM |
10.1006/bbrc.2001.6000 |
| Homo sapiens |
P-glycoprotein 1 |
IC50 |
7100.0 |
nM |
10.1006/bbrc.2001.6000 |
| Homo sapiens |
P-glycoprotein 1 |
IC50 |
11700.0 |
nM |
10.1006/bbrc.2001.6000 |
| Homo sapiens |
P-glycoprotein 1 |
IC50 |
14600.0 |
nM |
10.1006/bbrc.2001.6000 |
| Homo sapiens |
P-glycoprotein 1 |
IC50 |
17500.0 |
nM |
10.1023/a:1007568811691 |
| Homo sapiens |
P-glycoprotein 1 |
IC50 |
25800.0 |
nM |
10.1006/bbrc.2001.6000 |
| Homo sapiens |
P-glycoprotein 1 |
Inhibition |
100.0 |
% |
10.1021/jm021012t |
| Homo sapiens |
P-glycoprotein 1 |
Inhibition |
100.0 |
% |
None |
| Homo sapiens |
P-glycoprotein 1 |
% maximum response |
102.0 |
% |
None |
| Homo sapiens |
P-glycoprotein 1 |
Papp |
614.0 |
nm/s |
None |
| Homo sapiens |
P-glycoprotein 1 |
Papp |
661.0 |
nm/s |
None |
| Homo sapiens |
P-glycoprotein 1 |
Ratio_ATPase activity |
5.39 |
None |
None |
| Homo sapiens |
P-glycoprotein 1 |
Ratio_Papp |
1.08 |
None |
None |
| Homo sapiens |
Phosphodiesterase 3A |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Phosphodiesterase 4A |
AC50 |
8450.5 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Pregnane X receptor |
Activity |
nan |
None |
None |
| Homo sapiens |
Prelamin-A/C |
Potency |
1995.3 |
nM |
None |
| Homo sapiens |
Progesterone receptor |
AC50 |
1511.5 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Ras-related protein Rab-9A |
Potency |
58047.9 |
nM |
None |
| Homo sapiens |
Serine/threonine-protein kinase mTOR |
Activity |
nan |
None |
10.1073/pnas.0709695104 |
| Homo sapiens |
Serine/threonine-protein kinase mTOR |
Potency |
18492.7 |
nM |
None |
| Homo sapiens |
Serine/threonine-protein kinase mTOR |
Potency |
23280.9 |
nM |
None |
| Homo sapiens |
Serine/threonine-protein kinase mTOR |
Potency |
26121.6 |
nM |
None |
| Homo sapiens |
Serotonin 1a (5-HT1a) receptor |
AC50 |
2174.8 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2b (5-HT2b) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin transporter |
AC50 |
21517.9 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serum albumin |
PPB |
95.0 |
% |
10.1021/acs.jmedchem.5b01324 |
| Homo sapiens |
SH-SY5Y |
Potency |
19952.6 |
nM |
None |
| Homo sapiens |
Sodium channel protein type V alpha subunit |
AC50 |
7599.9 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Solute carrier organic anion transporter family member 1B1 |
Inhibition |
65.1 |
% |
10.1021/jm300212s |
| Homo sapiens |
Solute carrier organic anion transporter family member 1B3 |
Inhibition |
10.1 |
% |
10.1021/jm300212s |
| Homo sapiens |
Solute carrier organic anion transporter family member 2B1 |
Inhibition |
31.8 |
% |
10.1021/jm300212s |
| Homo sapiens |
Survival motor neuron protein |
Potency |
35481.3 |
nM |
None |
| Homo sapiens |
Thrombin |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Thromboxane A2 receptor |
AC50 |
4912.7 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Thromboxane A2 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Tyrosyl-DNA phosphodiesterase 1 |
Potency |
9441.1 |
nM |
None |
| Homo sapiens |
Tyrosyl-DNA phosphodiesterase 1 |
Potency |
13335.9 |
nM |
None |
| Homo sapiens |
Tyrosyl-DNA phosphodiesterase 1 |
Potency |
17229.0 |
nM |
None |
| Homo sapiens |
Tyrosyl-DNA phosphodiesterase 1 |
Potency |
44668.4 |
nM |
None |
| Homo sapiens |
Tyrosyl-DNA phosphodiesterase 1 |
Potency |
56234.1 |
nM |
None |
| Homo sapiens |
Ubiquitin carboxyl-terminal hydrolase 1 |
Potency |
28183.8 |
nM |
None |
| Homo sapiens |
Ubiquitin carboxyl-terminal hydrolase 1 |
Potency |
35481.3 |
nM |
None |
| Homo sapiens |
Vanilloid receptor |
Activity |
nan |
None |
10.1016/j.bmc.2008.08.048 |
| Homo sapiens |
Vascular endothelial growth factor receptor 2 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Vitamin D receptor |
Potency |
79432.8 |
nM |
None |
| Homo sapiens |
Vitamin D receptor |
Potency |
89125.1 |
nM |
None |
| Homo sapiens |
Voltage-gated L-type calcium channel alpha-1C subunit |
AC50 |
50000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Voltage-gated L-type calcium channel alpha-1C subunit |
IC50 |
250.0 |
nM |
10.1002/jat.2784 |
| Homo sapiens |
Voltage-gated L-type calcium channel alpha-1C subunit |
IC50 |
9600.0 |
nM |
10.1002/jat.2784 |
| Homo sapiens |
Voltage-gated L-type calcium channel alpha-1C subunit |
IC50 |
24100.0 |
nM |
10.1002/jat.2784 |
| Leishmania amazonensis |
Leishmania amazonensis |
IC50 |
26500.0 |
nM |
10.1016/j.bmc.2010.09.015 |
| Leishmania braziliensis |
Leishmania braziliensis |
IC50 |
19080.0 |
nM |
10.1016/j.bmc.2010.09.015 |
| Leishmania chagasi |
Leishmania chagasi |
IC50 |
22000.0 |
nM |
10.1016/j.bmc.2010.09.015 |
| Leishmania chagasi |
Leishmania chagasi |
IC50 |
35660.0 |
nM |
10.1016/j.bmc.2010.09.015 |
| Leishmania major |
Leishmania major |
IC50 |
21830.0 |
nM |
10.1016/j.bmc.2010.09.015 |
| Macaca fascicularis |
Brain |
Fu |
0.006 |
None |
10.1124/dmd.111.038778 |
| Macaca mulatta |
LLC-MK2 |
IC50 |
71590.0 |
nM |
10.1016/j.bmc.2010.09.015 |
| Mus musculus |
Brain |
Fu |
0.004 |
None |
10.1124/dmd.111.038778 |
| Mus musculus |
Indoleamine 2,3-dioxygenase 2 |
Inhibition |
55.0 |
% |
10.1016/j.bmcl.2012.10.010 |
| Mus musculus |
Mus musculus |
ID50 |
30.0 |
mg.kg-1 |
10.1021/jm00400a006 |
| Mus musculus |
P-glycoprotein 1 |
IC50 |
8000.0 |
nM |
10.1021/jm021012t |
| Mus musculus |
P-glycoprotein 3 |
IC50 |
2500.0 |
nM |
10.1021/jm021012t |
| Mus musculus |
Transient receptor potential cation channel subfamily A member 1 |
EC50 |
500.0 |
nM |
10.1021/jm100062h |
| Mus musculus |
Transient receptor potential cation channel subfamily M member 7 |
Inhibition |
nan |
% |
None |
| Oryctolagus cuniculus |
Oryctolagus cuniculus |
EC30 |
5.2 |
M |
10.1021/jm00400a006 |
| Oryctolagus cuniculus |
Oryctolagus cuniculus |
ID50 |
1e-09 |
M |
10.1021/jm00360a001 |
| Oryctolagus cuniculus |
Oryctolagus cuniculus |
ID50 |
1.9e-09 |
M |
10.1021/jm00360a001 |
| Plasmodium falciparum |
Plasmodium falciparum |
Potency |
1694.4 |
nM |
None |
| Plasmodium falciparum |
Plasmodium falciparum |
Potency |
16944.1 |
nM |
None |
| Rattus norvegicus |
Adenosine A1 receptor |
Ki |
19600.0 |
nM |
10.1021/jm9600205 |
| Rattus norvegicus |
Adenosine A2a receptor |
Ki |
63800.0 |
nM |
10.1021/jm9600205 |
| Rattus norvegicus |
Adenosine A3 receptor |
Inhibition |
7.94 |
% |
10.1021/jm9600205 |
| Rattus norvegicus |
Adenosine A3 receptor |
Inhibition |
27.2 |
% |
10.1021/jm9600205 |
| Rattus norvegicus |
Adenosine A3 receptor |
Ki |
11000.0 |
nM |
10.1021/jm9600205 |
| Rattus norvegicus |
Adenosine receptor A2a and A3 |
Ratio |
5.8 |
None |
10.1021/jm9600205 |
| Rattus norvegicus |
Adenosine receptors; A1 & A3 |
Ratio |
1.78 |
None |
10.1021/jm9600205 |
| Rattus norvegicus |
Adrenergic receptor alpha-1 |
IC50 |
3600.0 |
nM |
10.1021/jm00126a042 |
| Rattus norvegicus |
Adrenergic receptor alpha-1 |
IC50 |
10000.0 |
nM |
10.1021/jm00126a042 |
| Rattus norvegicus |
Adrenergic receptor alpha-2 |
IC50 |
1400.0 |
nM |
10.1021/jm00126a042 |
| Rattus norvegicus |
Brain |
Fu |
0.005 |
None |
10.1124/dmd.111.038778 |
| Rattus norvegicus |
Brain |
Fu |
0.008 |
None |
10.1124/dmd.111.038778 |
| Rattus norvegicus |
Equilibrative nucleoside transporter 1 |
Ki |
5360.0 |
nM |
10.1021/jm9600205 |
| Rattus norvegicus |
Ileum |
Inhibition |
70.0 |
% |
10.1007/s00044-007-9078-8 |
| Rattus norvegicus |
Inositol monophosphatase 1 |
Potency |
12589.3 |
nM |
None |
| Rattus norvegicus |
Liver |
IC50 |
100.0 |
nM |
10.1002/hep.27206 |
| Rattus norvegicus |
Peripheral myelin protein 22 |
Potency |
5102.8 |
nM |
None |
| Rattus norvegicus |
Plasma |
Fu |
0.01 |
None |
10.1021/jm901371v |
| Rattus norvegicus |
Plasma |
logFu |
0.05 |
None |
10.1016/j.ejmech.2009.06.004 |
| Rattus norvegicus |
Rattus norvegicus |
CL |
115.0 |
mL.min-1.kg-1 |
10.1021/jm991030j |
| Rattus norvegicus |
Rattus norvegicus |
Clearance |
27.0 |
ul min-1 |
10.1021/jm991030j |
| Rattus norvegicus |
Rattus norvegicus |
Hill coefficient |
1.054 |
None |
10.1021/jm00162a013 |
| Rattus norvegicus |
Rattus norvegicus |
IC50 |
0.026 |
nM |
10.1021/jm00126a042 |
| Rattus norvegicus |
Rattus norvegicus |
IC50 |
1400.0 |
nM |
10.1016/s0960-894x(00)00651-x |
| Rattus norvegicus |
Thoracic artery |
Inhibition |
15.9 |
% |
10.1007/s00044-007-9078-8 |
| Rattus norvegicus |
Vanilloid receptor |
Activity |
nan |
None |
10.1016/j.bmc.2008.08.048 |
| Rattus norvegicus |
Voltage-gated L-type calcium channel |
IC50 |
2.66 |
nM |
10.1021/jm00130a029 |
| Rattus norvegicus |
Voltage-gated L-type calcium channel |
Ki |
0.84 |
nM |
10.1021/jm00162a013 |
| Saccharomyces cerevisiae |
Eukaryotic peptide chain release factor GTP-binding subunit |
Inhibition |
0.0 |
% |
10.1038/nchembio.65 |
| Saccharomyces cerevisiae |
Eukaryotic peptide chain release factor GTP-binding subunit |
Inhibition |
50.0 |
% |
10.1038/nchembio.65 |
| Saccharomyces cerevisiae |
Eukaryotic peptide chain release factor GTP-binding subunit |
Inhibition |
55.0 |
% |
10.1038/nchembio.65 |
| Saccharomyces cerevisiae |
Eukaryotic peptide chain release factor GTP-binding subunit |
Inhibition |
61.5 |
% |
10.1038/nchembio.65 |
| Saccharomyces cerevisiae |
Eukaryotic peptide chain release factor GTP-binding subunit |
Inhibition |
88.0 |
% |
10.1038/nchembio.65 |
| Saccharomyces cerevisiae |
Eukaryotic peptide chain release factor GTP-binding subunit |
Inhibition |
nan |
% |
10.1038/nchembio.65 |
| Saccharomyces cerevisiae |
Saccharomyces cerevisiae |
Potency |
1835.6 |
nM |
None |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Hit score |
0.1855 |
None |
10.1101/2020.04.21.054387 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
IC50 |
19952.62 |
nM |
10.6019/CHEMBL4651402 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
IC50 |
20000.0 |
nM |
10.6019/CHEMBL4651402 |
| Staphylococcus aureus |
Quinolone resistance protein norA |
FC |
8.0 |
None |
10.1021/acs.jmedchem.6b01439 |
| Staphylococcus aureus |
Quinolone resistance protein norA |
FC |
16.0 |
None |
10.1021/acs.jmedchem.6b01439 |
| Staphylococcus aureus |
Quinolone resistance protein norA |
IC50 |
22800.0 |
nM |
10.1021/acs.jmedchem.6b01439 |
| Staphylococcus aureus |
Quinolone resistance protein norA |
Inhibition |
77.1 |
% |
10.1021/acs.jmedchem.6b01439 |
| Staphylococcus aureus |
Staphylococcus aureus |
Activity |
nan |
None |
10.1021/acs.jmedchem.6b01439 |
| Staphylococcus aureus |
Staphylococcus aureus |
GI |
nan |
None |
10.1021/acs.jmedchem.6b01439 |
| Sus scrofa |
Malate dehydrogenase mitochondrial |
IC50 |
49.0 |
None |
10.1021/jm030191r |
| Sus scrofa |
Malate dehydrogenase mitochondrial |
IC50 |
nan |
None |
10.1021/jm030191r |
| Sus scrofa |
Sus scrofa |
IC50 |
0.3 |
nM |
10.1021/jm00126a042 |
| Trypanosoma cruzi |
Trypanosoma cruzi |
IC50 |
10590.0 |
nM |
10.1016/j.bmc.2010.09.015 |
| None |
ADMET |
Activity |
120.0 |
mg |
10.1021/acs.jmedchem.0c00524 |
| None |
ADMET |
Activity |
nan |
None |
10.1016/j.bmc.2010.09.015 |
| None |
ADMET |
B(DPB) |
93.4 |
% |
10.1021/jm040760a |
| None |
ADMET |
CL |
7.0 |
mL.min-1.kg-1 |
10.1002/jps.20373 |
| None |
ADMET |
CL |
11.0 |
mL.min-1.kg-1 |
10.1124/dmd.108.020479 |
| None |
ADMET |
CL |
27.0 |
mL.min-1.kg-1 |
10.1002/jps.20373 |
| None |
ADMET |
CL |
37.0 |
mL.min-1.kg-1 |
10.1021/jm00159a022 |
| None |
ADMET |
CL |
48.0 |
mL.min-1.kg-1 |
10.1002/jps.20373 |
| None |
ADMET |
CL |
115.0 |
mL.min-1.kg-1 |
10.1002/jps.20373 |
| None |
ADMET |
CL |
150.0 |
uL.min-1.(10^6cells)-1 |
10.6019/CHEMBL3301361 |
| None |
ADMET |
Cmax |
184.0 |
nM |
10.1021/jm030191r |
| None |
ADMET |
Compound recovery |
70.0 |
% |
10.1124/dmd.110.036988 |
| None |
ADMET |
delta logD |
-0.72 |
None |
10.1021/jm0000564 |
| None |
ADMET |
DNAUC |
1.1 |
kg.min/L |
10.1080/00498250400028197 |
| None |
ADMET |
DNAUC |
2.0 |
kg.min/L |
10.1080/00498250400028197 |
| None |
ADMET |
DNAUC |
3.84 |
kg.min/L |
10.1080/00498250400028197 |
| None |
ADMET |
DNAUC |
10.0 |
kg.min/L |
10.1080/00498250400028197 |
| None |
ADMET |
F |
49.0 |
% |
10.1021/jm0000564 |
| None |
ADMET |
Fu |
0.003 |
None |
10.1124/dmd.110.036988 |
| None |
ADMET |
Fu |
0.004 |
None |
10.1124/dmd.111.038778 |
| None |
ADMET |
Fu |
0.005 |
None |
10.1124/dmd.110.036988 |
| None |
ADMET |
Fu |
0.008 |
None |
10.1124/dmd.110.036988 |
| None |
ADMET |
MRT |
1.5 |
hr |
10.1124/dmd.108.020479 |
| None |
ADMET |
Papp |
2.2 |
ucm/s |
10.1124/dmd.110.034629 |
| None |
ADMET |
Papp |
2.6 |
ucm/s |
10.1124/dmd.110.034629 |
| None |
ADMET |
Papp |
4.2 |
ucm/s |
10.1124/dmd.110.034629 |
| None |
ADMET |
Papp |
5.0 |
ucm/s |
10.1124/dmd.110.034629 |
| None |
ADMET |
Plasma half life |
17.0 |
hr |
10.1021/jm00159a022 |
| None |
ADMET |
PPB |
99.6 |
% |
10.6019/CHEMBL3301361 |
| None |
ADMET |
PPB |
99.61 |
% |
10.6019/CHEMBL3301361 |
| None |
ADMET |
Ratio |
-16.0 |
None |
10.1124/dmd.110.034629 |
| None |
ADMET |
Ratio |
0.0 |
None |
10.1124/dmd.110.034629 |
| None |
ADMET |
Ratio |
0.5 |
None |
10.1124/dmd.110.034629 |
| None |
ADMET |
Ratio |
16.0 |
None |
10.1124/dmd.110.034629 |
| None |
ADMET |
T1/2 |
4.1 |
hr |
10.1124/dmd.108.020479 |
| None |
ADMET |
Vd |
3.5 |
L.kg-1 |
10.1021/jm00159a022 |
| None |
ADMET |
Vdss |
0.64 |
L.kg-1 |
10.1002/jps.20373 |
| None |
ADMET |
Vdss |
1.0 |
L.kg-1 |
10.1124/dmd.108.020479 |
| None |
ADMET |
Vdss |
1.3 |
L.kg-1 |
10.1002/jps.20373 |
| None |
ADMET |
Vdss |
1.3 |
mL/min/kg |
10.1002/jps.20373 |
| None |
ADMET |
Vdss |
1.9 |
L.kg-1 |
10.1002/jps.20373 |
| None |
Hepatotoxicity |
Alkaline Phosphatase Increase - Activity Score |
nan |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
Alkaline Phosphatase Increase - Index Value |
2.0 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
Alkaline Phosphatase Increase - Number of Reports |
4.0 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
Composite Activity - Active |
0.0 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
Composite Activity - Marginal |
1.0 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
Composite Activity - Score |
nan |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
GGT Increase - Activity Score |
nan |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
GGT Increase - Index Value |
0.4 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
GGT Increase - Number of Reports |
4.0 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
HepSE_bilirubinemia |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_cholecystitis |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_cholelithiasis |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_cirrhosis |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_Combined Scores |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_elevated liver function tests |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_hepatic failure |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_hepatic necrosis |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_hepatitis |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_hepatomegaly |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_jaundice |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_liver disease |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_liver fatty |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_liver function tests abnormal |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
LDH Increase - Activity Score |
nan |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
LDH Increase - Index Value |
0.9 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
LDH Increase - Number of Reports |
4.0 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
SGOT Increase - Activity Score |
nan |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
SGOT Increase - Index Value |
3.0 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
SGOT Increase - Number of Reports |
4.0 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
SGPT Increase - Activity Score |
nan |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
SGPT Increase - Index Value |
2.5 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
SGPT Increase - Number of Reports |
4.0 |
None |
10.2174/1570163043334794 |
| None |
NON-PROTEIN TARGET |
Activity |
nan |
None |
10.1021/acs.jmedchem.9b00258 |
| None |
NON-PROTEIN TARGET |
Fu |
0.006 |
None |
10.1124/dmd.111.038778 |
| None |
NON-PROTEIN TARGET |
Fu |
0.01 |
None |
10.1124/dmd.108.020479 |
| None |
NON-PROTEIN TARGET |
Fu |
0.095 |
None |
10.1021/jm401963n |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (acute) |
0.0 |
% |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (animal toxicity known) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (benign tumour) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (granulomatous hepatitis) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (mechanism) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (moderate) |
6.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (moderate) |
6.7 |
% |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (time to onset) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
No relevant target |
K1 |
100.0 |
uM |
10.1021/jm00051a017 |
| None |
No relevant target |
K2 |
26.0 |
uM |
10.1021/jm00051a017 |
| None |
No relevant target |
LogD |
1.18 |
None |
10.1021/jm0000564 |
| None |
No relevant target |
LogD7.4 |
4.25 |
None |
10.1021/jm040760a |
| None |
No relevant target |
Log Kmemb |
2.5 |
None |
10.1021/jm0309001 |
| None |
No relevant target |
LogP |
5.5 |
None |
10.1021/jm021012t |
| None |
No relevant target |
pKa |
7.17 |
None |
10.1021/jm040760a |
| None |
No relevant target |
pKa |
7.2 |
None |
10.1124/dmd.110.036988 |
| None |
No relevant target |
pKa |
7.6 |
None |
10.1016/j.ejmech.2009.06.004 |
| None |
No relevant target |
pKa |
7.6 |
None |
10.1021/jm0000564 |
| None |
No relevant target |
pKa_B1 |
7.26 |
None |
10.6019/CHEMBL3301361 |
| None |
No relevant target |
pKa_B2 |
nan |
None |
10.6019/CHEMBL3301361 |
| None |
No relevant target |
Solubility |
5010.0 |
nM |
10.1016/j.ejmech.2019.111589 |
| None |
No relevant target |
Solubility |
7400.0 |
nM |
10.6019/CHEMBL3301361 |
| None |
No relevant target |
Solubility |
10000.0 |
nM |
10.1016/j.bmcl.2019.126721 |
| None |
Unchecked |
Ac50 |
10.0 |
uM |
None |
| None |
Unchecked |
Ac50 |
12.59 |
uM |
None |
| None |
Unchecked |
Ac50 |
17.78 |
uM |
None |
| None |
Unchecked |
Ac50 |
19.95 |
uM |
None |
| None |
Unchecked |
Ac50 |
28.18 |
uM |
None |
| None |
Unchecked |
Ac50 |
39.81 |
uM |
None |
| None |
Unchecked |
AC50 |
10000.0 |
nM |
None |
| None |
Unchecked |
AC50 |
12589.3 |
nM |
None |
| None |
Unchecked |
AC50 |
17782.8 |
nM |
None |
| None |
Unchecked |
AC50 |
19952.6 |
nM |
None |
| None |
Unchecked |
AC50 |
28190.0 |
nM |
None |
| None |
Unchecked |
AC50 |
39810.7 |
nM |
None |
| None |
Unchecked |
Activity |
107.0 |
RFU/min |
10.1021/acs.jmedchem.8b00986 |
| None |
Unchecked |
Activity |
nan |
None |
10.1021/np100213a |
| None |
Unchecked |
Activity |
nan |
None |
10.1128/aac.01184-06 |
| None |
Unchecked |
Anticonvulsant activity |
nan |
None |
10.1016/s0960-894x(03)00535-3 |
| None |
Unchecked |
EC50 |
4700.0 |
nM |
10.1021/acs.jmedchem.8b00986 |
| None |
Unchecked |
FC |
13.6 |
None |
10.1021/acs.jmedchem.8b00986 |
| None |
Unchecked |
Hepatotoxicity (acute) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (association with vascular disease) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (choleostasis) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (chronic liver disease) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (cirrhosis) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (comment) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (cytolytic) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (malignant tumour) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (severe hepatitis) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (steatosis) |
1.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (successful reintroduction) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Inhibition |
22.7 |
% |
10.1038/nchembio.65 |
| None |
Unchecked |
Potency |
6309.6 |
nM |
None |
| None |
Unchecked |
Potency |
8199.5 |
nM |
None |
| None |
Unchecked |
Potency |
10000.0 |
nM |
None |
| None |
Unchecked |
Potency |
12589.3 |
nM |
None |
| None |
Unchecked |
Potency |
16136.6 |
nM |
None |
| None |
Unchecked |
Potency |
16353.5 |
nM |
None |
| None |
Unchecked |
Potency |
16360.1 |
nM |
None |
| None |
Unchecked |
Potency |
25118.9 |
nM |
None |
| None |
Unchecked |
Potency |
31622.8 |
nM |
None |
| None |
Unchecked |
Ratio |
0.0 |
None |
10.1093/toxsci/kft176 |
| None |
Unchecked |
Ratio |
0.004 |
None |
10.1093/toxsci/kft176 |
| None |
Unchecked |
Ratio |
3.38 |
None |
10.1021/jm9600205 |
| None |
Unchecked |
Selectivity Index |
3.25 |
None |
10.1016/j.bmc.2010.09.015 |
| None |
Unchecked |
Selectivity Index |
6.76 |
None |
10.1016/j.bmc.2010.09.015 |